News ReleaseView printer-friendly version
Quidel to Present at the S.G. Cowen 23rd Annual Health Care Conference on March 19, 2003 at 10:00 A.M. EST
Investors may access an Internet Web cast of the presentation in the Investor Information section of the Company's Web site at www.quidel.com. The Web cast of the presentation and Q&A will be available for 30 days at the above Web address.
Quidel Corporation, a worldwide company helping women and their families live healthy lives, discovers, develops, manufactures and markets rapid point-of-care diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions associated with women's health in areas such as reproduction and diseases of the elderly. Quidel also provides point-of-care diagnostics for infectious diseases, including influenza A and B, Strep throat, H. pylori infection, chlamydia, infectious mononucleosis and infectious vaginitis. Quidel's products are sold to healthcare professionals for use in physician offices, clinical laboratories and pharmacies, and to consumers through organizations that provide private label, store brand products. These tests provide diagnostic information that enables rapid treatment and improves health outcomes, lowers costs and increases patient satisfaction. For more information, please visit Quidel's Web site at www.quidel.com.
Paul E. Landers, 858/552-7962
Lippert/Heilshorn & Associates
Ina McGuinness (email@example.com)
Bruce Voss (firstname.lastname@example.org)